All Posts: breast cancer
-
Biology Behind New Drug Used to Treat Triple-Negative Breast Cancer Uncovered
How TTP488 (azeliragon), an experimental drug, impairs aggressive, triple-negative breast cancer from metastasizing has been uncovered at the cellular level, according to researchers at Georgetown University’s Lombardi Comprehensive Cancer Center.
Category: News Release
-
Research To Help Patients Make Informed Decisions About Breast MRI
While many people think that breast cancer screening and mammography are synonymous, Claire Conley, PhD, wants people to know that women who are at higher than average risk for breast cancer may also receive a breast MRI.
Category: Lombardi Stories
-
Women with Elevated Breast Cancer Risk Could See Mortality Benefit from Estrogen-Blocking Drugs
WASHINGTON (Thursday, December 1, 2022) — While it has long been recognized that drugs that block the cancer-promoting activity of estrogen reduce the risk of developing new breast cancers, a new computer modeling study led by researchers at Georgetown Lombardi Comprehensive Cancer Center and colleagues showed that these treatments could also reduce the risk of […]
Category: News Release
-
Study in Mice Suggests that Expression of Estrogen-Related Gene Can Impact Postmenopausal Breast Cancer Risk and Prevention Strategies
WASHINGTON (December 1, 2022) — In a study using a first-of-its-kind mouse model of aging that mimics breast cancer development in estrogen receptor-positive postmenopausal women, investigators at Georgetown Lombardi Comprehensive Cancer Center and colleagues have determined that over-expression, or switching on, of the Esr1 gene could lead to elevated risk of developing estrogen receptor-positive breast […]
Category: News Release
-
‘Lombardi Women’ Event Brings Together Local Businesswomen to Support Breast Cancer Research
(October 7, 2022) — Held in person for the first time since 2019, the 16th Annual Lombardi Women event brought together 450 businesswomen and 43 sponsoring companies from across the Washington area. The event took place October 6 at the Pavilions at Wolf Trap National Park. “For 16 years, this group of women has come […]
Category: Lombardi Stories
-
Long-term Study Supports Link Between Inflammation and Cognitive Problems in Older Breast Cancer Survivors
Researchers followed hundreds of survivors for years to examine suspected source of worrying symptoms. LOS ANGELES (September 30, 2022) — Scientists are still trying to understand why many breast cancer survivors experience troubling cognitive problems for years after treatment. Inflammation is one possible culprit. A new long-term study of older breast cancer survivors, published today […]
Category: News Release
-
Technique Developed in Mice Could Aid Detection of Cancer in Dense Breasts
WASHINGTON (September 14, 2022) — A two-pronged approach to imaging breast density in mice, developed by researchers at Georgetown Lombardi Comprehensive Cancer Center, resulted in better detection of changes in breast tissue, including spotting early signs of cancer. The researchers hope that this approach will be translated from mice and improve breast imaging for people; […]
Category: News Release
-
Informing Children of a Mother’s Genetic Cancer Risk Does Not Impact Their Health Behaviors
WASHINGTON (July 21, 2022) — Telling a child about their mother’s risk of hereditary breast and ovarian cancer does not adversely influence the offspring’s lifestyle or quality of life in the long term, according to a new study led by researchers at Georgetown Lombardi Comprehensive Cancer Center. The finding appeared July 21, 2022, in Pediatrics […]
Category: News Release
-
Ralph Lauren Corporate Foundation Makes Gift to Address Disparities in Cancer Care
Category: Lombardi Stories
-
Ralph Lauren Corporate Foundation Announces $25 Million Commitment to Five Cancer Centers Across America With Goal of Reducing Disparities in Cancer Care in Underserved Communities
Commitment Recognized by White House Cancer Moonshot Georgetown University to establish The Ralph Lauren Center for Cancer Prevention at Georgetown Lombardi Comprehensive Cancer Center in Washington, D.C. Memorial Sloan Kettering (MSK) Ralph Lauren Center to build upon 20-year partnership serving Harlem, New York, and surrounding communities Conquer Cancer®, the ASCO Foundation, to collaborate on the […]
Category: News Release